financetom
Business
financetom
/
Business
/
AT&T Says Its Network Did Not Cause Disruption During Trump Conference Call
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AT&T Says Its Network Did Not Cause Disruption During Trump Conference Call
Jul 1, 2025 3:30 AM

06:13 AM EDT, 07/01/2025 (MT Newswires) -- AT&T ( T ) said it is "working diligently to better understand the issue" after US President Donald Trump publicly criticized the company's equipment during a conference call.

"I'm doing a major conference call with faith leaders from all over the country, and AT&T ( T ) is totally unable to make their equipment work properly," Trump wrote in a social media post Monday afternoon.

The company said its initial analysis indicated that the disruption was caused by "an issue with the conference call platform" instead of its network.

"Unfortunately, this caused the delay, and we are working diligently to better understand the issue so we can prevent disruptions in the future," AT&T ( T ) said in a social media post.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FOCUS-Physical buyers win battle for copper market as funds retreat
FOCUS-Physical buyers win battle for copper market as funds retreat
Aug 19, 2024
LONDON, Aug 19 (Reuters) - Investors fleeing the copper market are likely to be sidelined for many months, leaving the field clear for physical players who expect demand in top consumer China and elsewhere to deteriorate over coming months and weigh on prices. A fund buying frenzy, based on an expected shortage of copper relative to demand, sparked a rally...
Burning Rock Biotech to Remove ADR From London Trading
Burning Rock Biotech to Remove ADR From London Trading
Aug 19, 2024
06:57 AM EDT, 08/19/2024 (MT Newswires) -- Burning Rock Biotech ( BNR ) said Monday it plans to request that its American Depositary Shares be removed from trading on the London Stock Exchange and to cancel the listing of its securities on the UK Financial Conduct Authority's official list. The depositary shares will continue to trade on the Nasdaq Global...
AstraZeneca-Backed Breast Cancer Treatment Under European Regulatory Review for Type II Variation
AstraZeneca-Backed Breast Cancer Treatment Under European Regulatory Review for Type II Variation
Aug 19, 2024
06:55 AM EDT, 08/19/2024 (MT Newswires) -- Daiichi Sankyo said Monday that a Type II Variation application for its breast cancer therapy Enhertu, jointly developed with AstraZeneca ( AZN ) , is now up for review with the European Medicines Agency. The application adds an indication of Enhertu as treatment for an advanced breast cancer that can't be surgically removed...
AstraZeneca, Daichi Sankyo get FDA Breakthrough Designation for Potential Breast Cancer Therapy
AstraZeneca, Daichi Sankyo get FDA Breakthrough Designation for Potential Breast Cancer Therapy
Aug 19, 2024
06:50 AM EDT, 08/19/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said Monday that Enhertu has been granted US Food and Drug Administration Breakthrough Therapy Designation for the treatment of some breast cancer indications. The companies said the designation applies to the treatment of inoperable or metastatic hormone receptor-positive HER2 low or ultra-low breast cancer in patients...
Copyright 2023-2026 - www.financetom.com All Rights Reserved